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Abstract
Small viruses that can infect bacteria, called bacteriophages, can be found in the soil.
These viruses are being examined as a potential treatment against bacterial infections when
antibiotics are not available or non-effective. Before viruses can be used as a medical treatment,
they must be studied extensively. Previous attempts to sequence the terminal end of the genome
of a bacteriophage QCM-11 (Quartz-Crystal-Microbalance-11: Q11) resulted in error. It is thought
that a covalently bound protein may be attached to Q11’s DNA, blocking sequencing of the
genome from the 5’ end. Proteins bound to the DNA of phages is not unheard of, a welldocumented phage, Phi29, has a protein bound to the 5’ terminal end of its DNA. Both phages
were studied to determine if Q11 has a terminally bound protein similar to Phi29. Phages Phi29
and Q11 were subjected to digestion by various restriction enzymes as well as a 5’ exonuclease.
If a protein is bound to the DNA of Q11 digestion by these nucleases would be blocked. The
remaining fragments of phage DNA were run on agarose and polyacrylamide gels. The results
from the experiment were not able to conclusively prove that a protein is bound to Q11 DNA.
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Introduction
Bacteria are among the most abundant organisms on the planet. Most bacteria are nonharmful and, in some cases, even essential for human life. They are also a source of infection
that affects all living organisms. Antibiotics are the most common form of treatment to combat
bacterial infections, but like all organisms, bacteria evolve and can become resistant to medical
treatment over time. A lack of other medical interventions to treat bacterial infections poses a
major public health risk. As antibiotics rush to keep up with evolving microorganisms, other
methods of combating bacterial infections need to be researched.
Like most species on the planet, bacteria have a natural predator. Viruses that infect
bacteria, known as bacteriophages or phages, are more abundant in nature than bacteria and
make up the largest percentage of host-parasite relationships on the planet. The overall research
is being conducted on bacteriophages as a potential future source of treatment for bacterial
infections.
Bacteriophage QCM-11 (Quartz-Crystal-Microbalance-11 - Q11) is thought to have a
protein that is covalently bound to the end of its’s DNA, similar to another small phage, Phi29.
The function of these covalently bound proteins is mostly unknown. For Phi29, the 5’ covalently
bound protein is thought to aid in the packaging of DNA into the head of the virus. 2 Further
exploration of the possible function of these genome-bound proteins will yield a better
understanding of how these proteins assist in the survival or virulence of the bacteriophage. A
better understanding about these species of bacteriophage, and terminally bound proteins in
general, allows researchers to determine whether Phi29 or Q11 could be used as novel
treatments for bacterial infections.

Purpose
Spores of the bacterial species Bacillus anthracis (B. anthracis), the causal agent of
anthrax, can be found as long-lasting endospores in soil. Because of this, anthrax poses a
constant danger of emergence in livestock and humans. Vaccinations against anthrax are not
available to the general public, and antibiotics to treat the infection are most effective when given
immediately after exposure.
Bacillus cereus (B. cereus) is a toxin-producing species of bacteria commonly associated
with symptoms of food poisoning. Like B. anthracis, B. cereus has the ability to form spores of
itself that allow it to survive harsh environmental conditions, and then repopulate in optimal
conditions. B. cereus’ widespread presence in the soil and resistance to basic decontamination
methods mean, like most foodborne illnesses, that it can infect humans and livestock through
contaminated food products. B. cereus has been increasingly linked to cases of nongastrointestinal-tract infections, many of which have been serious or life-threatening.
The most widely used treatments for B. cereus and B. anthracis infections are antibiotics,
which are not always effective. To help mitigate the health risks of B. cereus and B. anthracis
infections in humans and animals, studies are being conducted on viruses that can infect and kill
specific species of bacteria known as bacteriophages or phages. These phages are being studied
as a potential supportive treatment, along with antibiotics to treat Bacillus cereus and Bacillus
anthracis infections.
Phage Q11 has been identified as a bacteriophage that can infect Bacillus cereus and
Bacillus anthracis. Previous attempts to determine the genetic sequence of Q11 have been
unsuccessful. It is thought that a protein may be permanently bound to the end of Q11’s DNA
preventing it from being fully sequenced. This investigation aims to determine if a protein is

covalently (permanently) bound to the 5’ end of Q11’s DNA. Confirmation will allow further study
into the function of this protein and its role in Q11’s virulence and survival in host bacteria.

Literature Review
Background
Phage Phi29 which infects Bacillus subtilis (B. subtilis) has been positively identified as
having a 5’ protein covalently bound to the end of the phages linear DNA.

1, 2

Previous

investigations into Phi29 have confirmed the existence of a 5’ terminal protein bound to the end
of Phi29’s linear DNA.1,2 These experiments utilized restriction endonucleases, or restriction
enzymes, which cut phage DNA into smaller pieces. These pieces were subjected to treatment
with 5’ and 3’ exonucleases which degrade phage DNA from both ends (5’ and 3’) of the DNA.
The results of these experiments showed that there was a small section of DNA that could not be
degraded with 5’ exonuclease.2 Since this fragment of phage DNA could be degraded with 3’
exonuclease, the conclusion was made that something was bound to the phage DNA on the 5’
end that blocked the degradation of DNA by the 5’ exonuclease.
Assembly of the virus was done using radioactively labeled atoms. [3H] thymidine, used
for building DNA and [35S] methionine, used for building proteins were used.2 Another variation of
this experiment used [14C] thymidine and [14C] methionine.1 Viral proteins and DNA were
separated out using sucrose gradient sedimentation. Most viral proteins were banded together on
the gradient and were detected by measuring levels of radioactively labeled methionine. However,
a small amount of radioactively labeled methionine was detected in the DNA band, suggesting
some viral protein was bound to the phage DNA.1,2 Treatment of the protein-bound DNA with
various chemicals was not able to break the DNA-protein bond, suggesting the linkage was
covalent in nature.2

Proteins covalently bound to the 5’ end of small bacteriophage DNA are rare but not
unheard of. Q11 is a small bacteriophage that can infect Bacillus anthracis Sterne, a safe nonpathogenic (vaccine) strain of B. anthracis. Previous attempts to sequence the 5’ terminal
sequence of the bacteriophage Q11 were unsuccessful.3 The inability to sequence the end of
Q11’s DNA suggests there may be a similar covalently attached protein on the 5’ end of Q11’s
DNA, similar to Phi29.3,4,9 Like Phi29, a 5’ terminal protein could prevent the complete DNA
sequencing of Q11. Research completed by Emily Cornelius and Dr. Michael Walter in the
summer of 2019 on Q11 was inconclusive on the existence of a covalently bound 5’ terminal
protein.4,9

Relevance
Bacillus cereus has been widely documented as a potential agent of food-borne illnesses
causing gastrointestinal distress. Cases of B. cereus infections have also reported nongastrointestinal symptoms that can be serious or life-threatening.5, 6 Bacillus anthracis produces
a toxin that is a known bio-terrorism agent.7 Both of these bacterial species pose a risk to public
health. The development of new antibiotics to treat bacterial infections has dramatically slowed
down.8 The World Health Organization (WHO) has also confirmed that bacteria are becoming
increasingly resistant to antibiotics currently being used to treat infections, which is a major public
health emergency.8

Materials and Methods
Bacteriophage DNA
A stock from bacteriophage Phi29 was purchased from the Sylvain Moineau, Universite
Laval, in Quebec Canada. This stock of phage was grown up in B. subtilis strain 1046. Isolated
DNA was purified by Emily Cornelius and Michael Walter on 2019-12-10 following standard

methodology.10,11 Samples of purified phage DNA were stored in a freezer at -20 °C until use in
further experiments. Phage DNA was stored on ice when in use.
Bacteriophage Q11 was isolated from planted prairie soil, enriched with B. anthracis by
Michael Walter.10 This phage was triple-serially-isolated for purity before being increased on
plates of B. cereus before being harvested for phage DNA. This DNA was purified by
ultracentrifugation by Emily Cornelius and Michael Walter, using standard methods10, on 201906-18 before being stored in a freezer at -20 °C. Purified Q11 DNA was kept on ice while in use.

Enzyme Digestion of Phage DNA
Enzymatic digestion of bacteriophage DNA was a critical procedure for identifying
terminally bound proteins on bacteriophage DNA. For endonuclease (restriction enzyme: RE)
digestion, varying amounts of restriction enzyme, restriction enzyme buffer, bovine serum albumin
(BSA) diluted in Promega Multi-core RE buffer, phage DNA and sterile distilled water were
combined in microcentrifuge tubes. Restriction enzymes EcoRI 10 U/μL (ThermoFisher Scientific
ER0271, 5,000 units) and HindIII 10 U/μL (ThermoFisher Scientific ER0501, 5,000 units) were
used for DNA digestion. The buffers for EcoRI and HindIII were obtained from Promega
Corporation (Madison WI) product numbers R008A and R005A, respectively. The BSA and RE
buffers (Promega) served as stabilizing agents during enzyme digestion. Bacteriophage DNA
used in these experiments was isolated from phage Phi29 and phage Q11 on 2019-12-10 and
2019-06-18, respectively by Emily Cornelius and Michael Walter at the University of Northern
Iowa. Stocks of the bacteriophage DNA were used for enzyme digestion. Sterile distilled water
was made in house by autoclaving glass-distilled water for one hour. All reagents and enzymes
when not in use were stored in a freezer at -20 °C. While in use the reagents were kept on ice to
preserve enzyme activity.

Exonuclease digestion of Phage DNA was completed using 5’-> 3’ λ exonuclease (5’
exonuclease) 10 U/ μL (ThermoFisher Scientific, EN0562, 5,000 units) following digestion by
restriction enzyme EcoRI. This exonuclease was and stored in a freezer at -20 °C when not in
use. While in use the 5’ exonuclease was kept on ice to preserve enzyme activity.
Incubation of restriction enzymes and exonucleases was typically done in a water bath at
37 °C. Variations in temperature and incubation time are noted in the experimental results. After
incubation, NEB Stop Buffer made in-house (50% glycerol, 50 mM EDTA (pH 8.0), 0.05%
bromophenol blue (10 μl / 50 μl reaction) was added to the reaction to stop the activity of the
enzyme at a ratio of 1 μL NEB Stop solution to 5 μL of reaction mixture.

Gel Electrophoresis
Purified phage DNA, phage DNA digested by restriction enzymes EcoRI and HindIII, and
phage DNA digested by restriction enzyme EcoRI then digested again with 5’ exonuclease was
loaded onto gels for electrophoresis. The conditions listed in the methodology below is consistent
for each experiment run unless noted in the results section.

Agarose
Agarose gels work like a porous sponge. Naturally negatively charged DNA fragments
migrate through the holes of the sponge when an electric field is applied to them. Smaller
fragments are more easily able to pass through the holes of the gel. The larger the DNA fragments
are, the more tangled they get while passing through the gel and do not migrate as far down the
gel as smaller fragments. This allows DNA fragments to be separated by size and shape.
Phi29 and Q11 DNA restriction enzyme and exonuclease digests were run on 0.8%
agarose gels that were poured in the lab. The agarose for making the gels was obtained from
ThermoFisher Scientific. The gels were run at 80 V for 60 minutes then 40V for four hours in a

0.5X concentration of Tris-Borate-EDTA running buffer (TBE, pH 8.3). TBE buffer was diluted
from a stock 10X solution obtained from ThermoFisher Scientific (B52). Gels were stained with
ethidium bromide (EtBr), at a final concentration of 0.2-0.5 µg/mL in 0.5X TBE for 20 minutes.
After staining the gels were destained in TBE buffer then imaged on a UV lightbox using
Carestream Imaging Technology (Carestream Health, Inc, Rochester, NY).

SDS PAGE
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE) works similarly
to agarose gels in that a purified sample is passed through a porous gel using an electric field.
The fragments generally processed using SDS polyacrylamide are proteins because the holes in
the polyacrylamide gel are too small for DNA that get stuck at the top of the gel. Proteins are
denatured by boiling samples in Laemmli buffer (125 mM Tris-Cl pH 6.8, 4% SDS, 20% glycerol,
10% 2-mercaptoethanol) for 3 minutes. This linearizes and simultaneously coats the proteins with
sodium dodecyl sulfate (SDS). SDS imparts a negative charge and allows proteins to run through
the SDS-PAGE gel, being separated by size, not charge or shape. Purified Q11 DNA and Q11
DNA treated with restriction enzyme (RE) EcoRI at varying concentrations – then were analyzed
by SDS PAGE to reveal protein migration differences attributable to proteins attached to Q11
DNA. Treated DNA samples were loaded on and analyzed on 4–20% gradient Mini-PROTEAN®
TGX™ Precast Protein Gels, 10-well, 30 µl gels (Bio Rad, Hercules, CA, 4561093) and run in
standard SDS-PAGE ‘Tris-Glycine’ running buffer (25 mM Tris, 193 mM glycine, 0.1% SDS). The
gels were run at 150 V until markers reached the bottom of the gel, about 120 minutes.
After running, the proteins in the gel were treated with a fixative solution mixture of 40%
ethanol and 10% acetic acid. The gels were rinsed twice with distilled water for 20 minutes. After
rinsing the gels were stained with Coomassie Blue dye then extensively destained in the fixative
solution. The gels were silver stained using reagents and methodology from Bio Rad Silver Stain

Plus Kit, (Bio Rad, Hercules, CA, 1610449) and imaged by transmitted light (not UV) as described
above.

Results
The specific conditions for each experiment along with the results and gel images are
discussed below. Each experiment is date coded in year-month-day format. For example, April
5th 2020 would be coded as 200405.

200110 EcoRI Restriction Enzyme Digestion of Phi29 DNA
Phi29 DNA isolated and purified on December 10th of 2019 (191210) was treated with
restriction enzyme EcoRI and allowed to incubate for varying amounts of time to demonstrate the
efficacy of RE EcoRI on Phi29 DNA
Lanes one and twelve on the agarose gel contain 5μL of
1kb Generuler DNA ladder (ThermoFisher) each, as a standard
to measure the length of the restriction fragments. Lanes two
and eleven on the gel were left blank. Lane 3 was loaded with 5
μL of Phi29 DNA, 2 μL of 10x EcoRI Buffer H, 2 μL of BSA
diluted 10X in Promega Multi-core, 11 μL of sterile distilled water
for a total volume of 20 μL loaded. Lanes four through ten were
loaded with 20 μL each of a mixture containing 5 μL of Phi29
DNA, 2 μL of 10X EcoRI Buffer H, 2 μL of BSA diluted to 10X in Promega Multi-core, 2 μL of
EcoRI restriction enzyme, and 9 μL of sterile distilled water. The contents of lanes three and four
were not allowed to incubate, NEB Stop Buffer was added to the solution immediately after
addition of the restriction enzyme. Tubes five, six, seven, eight, nine and ten were allowed to
incubate for further enzyme digestion at 37 °C for one, two, three, six, eight, and ten minutes,

respectively, before NEB Stop Buffer was added to each tube. 20 μL of each mixture was added
to lanes three through ten on an agarose gel.
The amount of phage DNA used in this digestion was insufficient, though the decrease in
intensity of the phage DNA band is evident (Figure 1). The next digest of Phi29 DNA will use more
phage DNA. The results of this experiment confirm that EcoRI is effective at digesting Phi29 DNA.

200127 EcoRI and HindIII Restriction Enzyme Digestion of Phi29 DNA
Phi29 DNA from 191210 was treated with restriction enzymes
EcoRI and HindIII. Phi29 DNA digested with HindIII was allowed Figure 1. 200110 agarose gel of EcoRI digestion
of Phi29 DNA.

to incubate for varying amounts of time to confirm activity of the
restriction enzyme. More phage DNA was used in this experiment
after previous trials using 5 μL of phage DNA proved insufficient to
visualize restriction fragments on an agarose gel.
Lanes one and eight were loaded with 3 μL of 1kb Generuler
DNA ladder. Lane two was loaded with a 30 μL aliquot containing 5
μL of Phi29 DNA, 3 μL of EcoRI buffer H, 3 μL of BSA diluted to 10X
in Promega Multi-core, 19 μL of sterile distilled water and 6 μL of NEB
Stop buffer. Lane three was loaded with a 30 μL aliquot containing 20 Figure 2. 200127 agarose gel of EcoRI and
HindIII digestion of Phi29 DNA.

μL of Phi29 DNA, 3 μL of EcoRI buffer H, 3 μL of BSA diluted in
Promega Multi-core, 2 μL of sterile distilled water, 2 μL of EcoRI restriction enzyme. The contents
of lane 3 were allowed to incubate at 37 °C for 10 minutes before 6 μL of NEB Stop buffer was
added. Lanes four, five, six and seven were each loaded with an aliquot containing 20 μL of Phi29
DNA, 3 μL of HindIII Buffer E, 3 μL of BSA diluted to 10X in Promega Multi-core, 2 μL of sterile
distilled water and 2 μL of HindIII restriction enzyme. Each sample was allowed to incubate for
ten, fifteen, twenty, and thirty minutes, respectively, before 6 μL of NEB Stop buffer was added to

each mixture. The agarose gel was run for one hour at 80V and then at 40V for five hours before
being EtBr stained and imaged.
This experiment was a continuation from 200110 where 5 μL of Phi29 phage DNA
subjected to EcoRI digestion was not enough to produce visible bands on an agarose gel. The
results from this experiment (Figure 2) show that 20 μL of phage DNA produces undigested bands
that are very bright on the gel. There was too much phage DNA, not enough restriction enzyme
and not enough incubation time to digest the phage DNA to produce bands. Less phage DNA and
a longer incubation time could be used to produce visible bands.

200130 EcoRI and HindIII Restriction Enzyme Digestion of Phi29 DNA
To determine the appropriate concentration of
Phi29 DNA to load into the gel to produce visible bands
after restriction enzyme digestion, another round of
experiments similar to 200110 and 200127 was conducted.
More Phi29 phage DNA was used than the 200110
experiment, but less than the amount of DNA used in the
200127 experiment.
Lanes one and eight were loaded with 3 μL of 1 kb
Generuler DNA ladder. Lane two was loaded with a 20 μL
aliquot of a mixture containing 5 μL of Phi29 DNA, 3 μL of
EcoRI buffer H, 3 μL of BSA diluted to 10x in Promega
Multi-core, 9 μL of sterile distilled water and 4 μL of NEB
Stop buffer. Lanes three and four were loaded with a 20 μL

Figure 3. 200130 agarose gel of EcoRI and HindIII
digestion of Phi29 DNA.

aliquot of a mixture containing 10 μL of Phi29 DNA, 3 μL of EcoRI buffer H, 3 μL of BSA diluted
to 10x in Promega Multi-core, 2 μL of sterile distilled water and 2 μL of EcoRI restriction enzyme.
Both tubes were incubated at 37 °C for 30 minutes before 4 μL of NEB Stop buffer was added to

the mixture. Lane five was loaded with a 20 μL aliquot of a mixture containing 5 μL of Phi29 DNA,
3 μL of HindIII buffer E, 3 μL of BSA diluted to 10x in Promega Multi-core, 9 μL of sterile distilled
water and 4 μL of NEB Stop buffer. Lanes six and seven were loaded with a 20 μL aliquot of a
mixture containing 10 μL of Phi29 DNA, 3 μL of HindIII buffer E, 3 μL of BSA diluted to 10x in
Promega Multi-core, 2 μL of sterile distilled water and 2 μL of HindIII restriction enzyme. Both
tubes were incubated at 37 °C for 30 minutes before 4 μL of NEB Stop buffer was added to the
mixture. The agarose gel was run before being stained and imaged as described in the methods
section above.
The amounts of Phi29 DNA loaded in this experiment produced visible DNA on the gel
(Figure 3). However, digested Phi29 DNA fragments did not produce visible bands. Phi29 DNA
purified on 191210 appears to contain contaminants that caused the DNA on the gel to smear.
Phi29 is a well-documented bacteriophage for which enzyme restriction digests are known and
predictable. The primary use of Phi29 was to set up the conditions for running restriction enzyme
digests for Q11 DNA. The conditions for this experiment, in terms of concentration and incubation
time of reagents will be used in future runs using Q11 DNA.

200203 EcoRI and HindIII Restriction Enzyme Digestion of Q11 DNA
Phage Q11 DNA was subjected to the same
treatment as Phi 29 in the 200130 experiment. Phi29 DNA
was used in previous experiments as a model to adjust for
the right concentrations of DNA, enzyme and incubation
time to yield fragments. Phi29 is a well-studied and
documented bacteriophage whose results in our lab could
be compared to previous work with Phi29.
Lanes one and eight were loaded with 3 μL of 1 kb
Generuler DNA ladder. Lane two was loaded with a 20 μL
aliquot of a mixture containing 5 μL of Q11 DNA, 3 μL of
EcoRI buffer H, 3 μL of BSA diluted to 10x in Promega Multicore, 9 μL of sterile distilled water and 4 μL of NEB Stop
buffer. Lanes three and four were loaded with a 20 μL aliquot

Figure 4. 200203 agarose gel of Q11 DNA digested with
EcoRI and HindIII.

of a mixture containing 10 μL of Q11 DNA, 3 μL of EcoRI buffer H, 3 μL of BSA diluted to 10x in
Promega Multi-core, 2 μL of sterile distilled water and 2 μL of EcoRI restriction enzyme. Both
tubes were incubated at 37 °C for 30 minutes before 4 μL of NEB Stop buffer was added to the
mixture. Lane five was loaded with a 20 μL aliquot of a mixture containing 5 μL of Q11 DNA, 3 μL
of HindIII buffer E, 3 μL of BSA diluted to 10x in Promega Multi-core, 9 μL of sterile distilled water
and 4 μL of NEB Stop buffer. Lanes six and seven were loaded with a 20 μL aliquot of a mixture
containing 10 μL of Q11 DNA, 3 μL of HindIII buffer E, 3 μL of BSA diluted to 10x in Promega
Multi-core, 2 μL of sterile distilled water and 2 μL of HindIII restriction enzyme. Both tubes were
incubated at 37 °C for 30 minutes before 4 μL of NEB Stop buffer was added to the mixture.
The restriction enzyme digestion of Q11 DNA using EcoRI and HindIII was successful
(Figure 4). EcoRI digestion of Q11 yielded 9 visible fragments when run on agarose gel. HindIII

digestion of Q11 DNA yielded 17 visible fragments on agarose gel. These results are consistent
with previous digestions of Q11 DNA performed by Emily Cornelius and Michael Walter in the
summer of 2019.

200206 Large Scale EcoRI Restriction Enzyme Digestion of Q11 DNA
Q11 DNA digestion by EcoRI in the previous
experiment, 200203, successfully produced visible bands on
agarose gel. To continue experiments looking for a terminal
protein bound, large amounts of restriction digested Q11 are
needed. In this experiment larger amounts of Q11 DNA were
subjected to EcoRI restriction enzyme digestion to produce
Q11 DNA fragments.

Figure 5. 200206 agarose gel of Q11 DNA digested
by EcoRI.

Five tubes of EcoRI restriction enzyme digest of Q11 DNA were prepared. Each tube
contained 30 μL of Q11 DNA, 4 μL of EcoRI buffer H, 0.4 μL BSA diluted to 10x in Promega Multicore, 3.6 μL of sterile distilled water, and 2 μL of EcoRI restriction enzyme. Each sample was
incubated at 37 °C for two hours before 10 μL of NEB Stop solution was added to two samples.
The two samples containing NEB Stop solution were loaded onto an agarose gel in lanes two and
three to confirm EcoRI digestion. Lanes one and five on the gel were loaded with 3 μL of 1 kb
Generuler DNA ladder. Lanes four and six were left blank. The gel was run before being stained
and imaged. The three remaining samples of EcoRI digested Q11 DNA were stored in a freezer
at -20 °C for future use. These samples are referred to as EcoRI digests of Q11 DNA from 200206
in future experiments.
The digestion of Q11 DNA with EcoRI provided 9 visible bands on the agarose gel (Figure
5). These results match the previous results of EcoRI digestion of Q11 DNA on 200203. The Q11
DNA was not fully digested by EcoRI, a longer digestion time is recommended for the remaining
samples of EcoRI digested Q11 DNA.

200213 EcoRI Restriction Enzyme Digestion Fragments of Q11 DNA treated
with 5’ Exonuclease
Exonucleases, unlike restriction enzymes which cut DNA at specific recognition sites,
completely digest double stranded DNA from the 5’ or 3’ terminus, unless something is bound to
the end of the DNA, blocking activity of the exonuclease. If a 5’ terminal protein is covalently
bound to the end of Q11’s DNA the terminal protein should block the exonuclease from digesting
the protein, the DNA it is attached to.
A 5’ exonuclease (ThermoFisher) was added to EcoRI digested-Q11 DNA. Lane
one was loaded with 5 μL of 1 kb Generuler DNA ladder. Lane two was loaded with 25
μL of a mixture containing 20 μL of Q11 DNA treated with EcoRI restriction enzyme from
the 200206 experiment and 5 μL of NEB Stop solution. Lane three was loaded with 25 μL
of a mixture containing 20 μL of EcoRI digested Q11 DNA, 2 μL of 5’ exonuclease, 3 μL
of 5’ buffer and 5 μL of NEB Stop solution added to the solution after a two hour incubation
at 37 °C.
The EcoRI digestion of Q11 DNA produced most of the visible fragments shown
in previous experiments 200203 and 200206. There were no visible fragments visible on

Figure 6. 200213 5'
exonuclease and
EcoRI digestion of
Q11 DNA on
agarose gel.

the agarose gel after the 5’ exonuclease digestion of EcoRI digestion of Q11 DNA. A band
should be visible on the gel if a 5’ terminally bound protein was covalently bound Q11 DNA. The
absence of any bands after 5’ exonuclease digestion suggests that there is no protein bound to
Q11 DNA. Further experiments will test fragments of Q11 DNA treated with EcoRI on SDS
polyacrylamide gels, meant for protein separation. If a protein is bound to a Q11 DNA fragment it
may migrate through the SDS polyacrylamide gel on the DNA fragment producing a band.

200214 SDS PAGE Gel of Q11 DNA Untreated and Treated with EcoRI
SDS polyacrylamide gel electrophoresis (SDS PAGE) was performed on whole Q11 DNA
and Q11 DNA fragments treated with restriction enzyme EcoRI. SDS PAGE gels have smaller
pores than agarose gels and are typically used for protein separation. These experiments were
run with the idea that if a terminally bound protein exists it will migrate along with the DNA it is
bound to and produce a band on the SDS-PAGE gel. Two gels were run for each SDS experiment
to replicate results.
Lane 1 on gel 1 (Figure 7) was
loaded with 5 μL of BioRad ProteinPrecision-Plus

Marker

(PPP,

BioRad,

Hercules, CA). Lanes two, three and four
were loaded with 5 μL each of Q11 DNA
digested by restriction enzyme EcoRI on
200206 diluted to 0.1X, 0.01X, and 0.001X,
respectively. Lane five was loaded with 5 μL

Figure 7. 200214 SDS PAGE gel 1 of Q11 DNA and EcoRI treated Q11 DNA.
Silver Stain.

of restriction enzyme EcoRI diluted to a 1/25 dilution in sterile distilled water so as to match the
approximate amount of enzyme (protein) in the treated samples. Lane six was loaded with 1 μL

of undiluted restriction enzyme EcoRI. Lanes seven and eight were left blank. Lanes nine and ten
were loaded with 5 μL each of untreated Q11 DNA diluted to 0.01X and 0.1X, respectively.
Lanes one, two, and three on Gel 2
(Figure 8) were loaded with 5 μL of Q11 DNA
digested with EcoRI digest on 200206 diluted
to 0.01X, 0.001X, and 0.0001X, respectively.
Lane four was left blank. Lane five was loaded
with 5 μL of PPP Marker. Lane six was loaded
with restriction enzyme EcoRI diluted to a
1/100th dilution with sterile distilled water.

Figure 8. 200214 SDS PAGE gel 2 of Q11 DNA and EcoRI treated Q11 DNA.
Silver Stain.

Lanes seven, eight, and nine were loaded with 5 μL each of untreated Q11 DNA diluted to 0.01X,
0.001X, and 0.0001X respectively. Lane ten was left blank.
After loading, the SDS PAGE gel was run at 150 V for approximately three hours before
being fixed, stained with Coomassie Blue, destained, Silver Stained and imaged using the
methods described in the SDS PAGE methodology section. The results of this gel were surprising.
Most DNA is presumed to be too large to migrate through an SDS gel, usually causing the gel to
warp in the frame. However, every sample of DNA loaded into the gel appeared to migrate without
causing warping of the gel. Most concentrations of DNA loaded were too faint to be seen on the
silver stained image. On gel 2 (Figure 8), a faint potential band can be seen in lane seven where
untreated Q11 DNA was loaded at a 0.01X concentration. A band in the presence of Q11 DNA
could mean several things. The band appears in the most concentrated sample (0.01X) of Q11
DNA loaded onto this gel. The band could be a contaminant that is at a high enough concentration
to produce a band on the gel. The band appears to be roughly the same size (similar migration
distance) as the restriction enzyme EcoRI. The band could be spillover from loading EcoRI into
the lane next to it. The absence of a band on gel one where untreated Q11 DNA was loaded at

the same 0.01X concentration appears to support the hypothesis that this band is a contaminant.
Our hope is that this band is a protein fragment bound to Q11 DNA that migrated through the gel.
The possibility of this band being migrated protein on the DNA will continue to be explored in
future experiments.
This was also the first trial of an SDS gel run with Q11 DNA. Various concentrations of
things like DNA, EcoRI, and marker will be adjusted in further experiments to produce a clean gel
with bands of similar intensity when treated with silver stain.

200223 SDS PAGE Gel of Q11 DNA Untreated and Treated with EcoRI
Following the discovery of a band forming on gel 2 from the previous experiment (200214),
the concentrations of marker and restriction enzyme EcoRI were lessened and more Q11 DNA,
both untreated and treated with EcoRI from the 200206 experiment was used. The goal was to
produce a gel that had consistent intensity between the marker, restriction enzyme and phage
DNA when silver stained. More Q11 DNA at higher concentrations was used in an attempt to
reproduce results from 200214 where a band was found on gel 2 well 7 (Figure 8) where Q11

DNA was loaded at a 0.01X concentration. Two
polyacrylamide protein gels were run to replicate
results within this experiment.
For gel 1 (Figure 9), lane one was loaded
with 1 μL of marker at a 1x concentration. Lane
two was loaded with 5 μL of marker at a 0.01X
concentration. Lanes three and four were loaded
with Q11 DNA treated with EcoRI from 200206, 5

Figure 9. 200223 gel 1. SDS PAGE of Q11 untreated and EcoRI treated
DNA. Silver Stain.

μL at a 0.01X concentration and 10 μL at a
0.001X concentration, respectively. Lane five
was loaded with 5 μL of restriction enzyme EcoRI
at a 0.01X dilution. Lane six was left blank. Lanes
seven and eight were loaded with 10 μL each of
Q11 untreated DNA at a 0.1X and 0.01X
concentration respectively. Lane nine was left
blank. Lane ten was loaded with 10 μL of
untreated Q11 DNA at a 0.1X dilution.

Figure 10. 200223 gel 2. SDS PAGE of Q11 untreated and EcoRI treated
DNA. Silver Stain.

Gel 2 (Figure 10), lane one was loaded with 10 μL of 200206 EcoRI treated Q11 DNA at
a 0.001X concentration. Lane two was left blank. Lane three was loaded with marker diluted to
0.01X. Lane four was loaded with restriction enzyme EcoRI at a 0.001X concentration. Lane five
was left blank. Lanes six, seven, and eight were loaded with untreated Q11 DNA at a 1X, 0.1X,
and 0.01X concentration respectively. Lane nine was left blank. Lane ten was loaded with 5 μL of
untreated Q11 DNA.
All samples were treated as described above in the Materials and Methods section. The
dilution of the marker in gel 1 lane two (Figure 9) produced clearer bands than loading a smaller

amount of 1X marker. The 0.01X dilution of restriction enzyme EcoRI on gel 1 (Figure 9) produced
a band of similar intensity to the diluted marker in lane two after being silver stained. Untreated
Q11 DNA at a 1X concentration on gel 2 (Figure 10) lane six was the only DNA band to produce
something on the gel. The untreated Q11 DNA at 1X created a dark smear in its lane after being
stained. There were no bands visible for Q11 DNA, treated with EcoRI or untreated at any
concentration on the gel. Q11 DNA is surprisingly still able to migrate through the gel at every
concentration. There was no visible warping of gel in any place including Q11 DNA at the 1X
concentration. The grainy quality in both Figure 9 and 10 is due to the silver stain. All glassware
involved in making up the silver stain solution will be rinsed with nitric acid to clean the glassware
and reduce the grainy appearance of future gels.

200312 SDS PAGE Gel of Q11 DNA Untreated and Treated with EcoRI
This experiment is looking to either
confirm or deny the existence of the band seen
on gel 2 lane seven from the 200214 gel that was
not seen at any Q11 DNA concentration on the
20223 gel. Two gels were run for this experiment
to duplicate results.
Gel 1 lane one (Figure 11) was loaded
with 5 μL of marker at a 0.01X concentration.
Lanes two, three and four were loaded with 5, 10

Figure 11. 200312 gel 1. SDS PAGE of Q11 untreated and EcoRI
treated DNA. Silver Stain

and 15 μL, respectively, of 200206 EcoRI digested Q11 DNA. Lane five was loaded with 5 μL of
restriction enzyme EcoRI at a 0.01X dilution. Lane six was left blank. Lane seven was loaded with
10 μL of untreated Q11 DNA at a 0.1X concentration. Lane eight was loaded with 5 μL of untreated

Q11 DNA at a 1X concentration. Lane nine was left
blank. Lane ten was loaded with 10 μL of untreated
Q11 DNA at a 0.01X concentration.
Gel 2 lane one (Figure 12) was loaded with
10 μL of untreated Q11 DNA at a 0.1X
concentration. Lane 2 was loaded with 5 μL of
marker at a 0.01X concentration. Lane three was
loaded with 20 μL of untreated Q11 DNA at a 0.1X
concentration. Lane four was left blank. 5 μL of

Figure 12. 200312 gel 2. SDS PAGE of Q11 untreated and EcoRI
treated DNA. Silver Stain.

untreated Q11 DNA at a 1X concentration. Lane six was loaded with 5 μL of restriction enzyme
EcoRI at a 0.01X dilution. Lanes seven and eight were loaded with 10 and 20 μL respectively of
untreated Q11 DNA at a 0.01X concentration.
Similar to the 200223 experiment, no discernable DNA band was visible on the gel. Both
samples of restriction enzyme EcoRI produced a band, as well as the marker proteins loaded in
each gel. Untreated Q11 DNA loaded into the gel at a concentration at or above 0.01X produces
a smear that is stained in the lanes where the untreated DNA is loaded. After multiple attempts to
observe a band on the gel for the suspected Q11 protein, no band similar to the one observed on
200214 has been found.

Discussion
Conclusions
The absence of bands on the 5’ exonuclease (ThermoFisher) and EcoRI restriction
enzyme treated sample indicate that terminally bound protein may not exist on Q11’s DNA. Based
on previous studies of Phi29, which has a confirmed terminal protein, treatment with a 5’

exonuclease does produce fragments when run on a gel. The absence of results in our experiment
is worth another run of 5’ exonuclease λ digestion to confirm these results.
The presence of a band in the 200214 SDS-PAGE gel image where untreated Q11 DNA
at a 0.01X concentration was loaded, suggested that there may be a terminally bound protein that
migrated with the DNA it is attached to. Several other trials 200223 and 200312 were conducted
in an attempt to replicate the results seen on the 200214 gel. No concentration of Q11 DNA
treated with EcoRI or untreated was able to produce a band similar to what was observed on the
200214 gel. It can be concluded that the most likely cause of the band observed on the 200214
gel was either a contaminant or spillover from loading restriction enzyme EcoRI in the neighboring
well.
This research demonstrated there is not enough conclusive evidence to prove or disprove
the existence of a terminal protein covalently bound to the end of Q11’s DNA. The results of this
experiment suggest that a 5’ terminally bound protein may not exist despite earlier experiments3,4,9
suggesting that a 5’ terminal protein does exist for Q11. Further investigation is required to pursue
the idea that a protein may be bound to Q11 DNA.

Areas for further investigation
This research project was not able to conclusively prove that a protein is covalently bound
to the end of Q11’s 5’ DNA. While this research project is ongoing, the preliminary results
presented in this paper cannot conclude that a covalently bound protein is present on the 5’
terminal end of bacteriophage Q11’s DNA. Continued research into this topic will build upon the
methods and techniques in this paper to determine the existence of a covalently bound protein.
If Q11 can be shown to have a covalently bound protein on the end of its DNA, further
investigations will be conducted to isolate, replicate and determine the structure and function of
the protein in relation to Q11’s virulence and survival in the environment and inside of a bacterial

host. Several other options could be considered for something that blocks DNA sequencing of
Q11 on the terminal end. If no covalently bound protein can be found on the end Q11’s DNA
further investigation will be taken to understand why Q11 DNA was previously unable to be
sequenced in previous experiments.3
The understanding of bacteriophages that can kill and infect bacterial species is critical for
both a more developed scientific understanding and as an emerging healthcare tool to treat
bacterial infections. Every drug that passes inspection through the Food and Drug Administration
(FDA) must be studied and researched carefully before the product is released onto the market
for patient treatment. The same is absolutely true, if not more so for viruses as a potential
treatment for bacterial infections. This is a type of biotechnology that has been historically
developed but is only recently seeing use against human bacterial infections. Our current
healthcare system has relied on antibiotics to treat bacterial infections for almost a century.
Bacteria may lack complexity but compensate at the rate at which they are constantly dividing
and growing. Constant treatment of bacterial infections with a limited number of antibiotics has
led to bacterial resistance to the antibiotics that we rely on to kill them. Novel methods of treating
bacterial infections need to be explored.
Bacteriophages are viruses that naturally infect and kill bacteria. These phages replicate
at a much faster rate than bacteria, potentially only requiring a small dose of phage that will rapidly
replicate in the body to fight a bacterial infection. Because viruses have a much quicker replication
cycle than bacteria, they can constantly evolve to evade bacterial defenses to ward off infection,
like they have been doing for millions of years. It makes sense, as we move into a new era of
biotechnology, to consider using phages that have evolutionarily evolved over hundreds of
millions of years to infect and kill bacteria as a novel treatment when antibiotics no longer work.
Research into novel medical treatments takes time. Years of work need to be put into
understanding these viruses before they are able to be tested for medical purposes. Every aspect

of these viruses needs to be understood down to the genetic information that encodes and evolves
for their survival. It is thought that terminal proteins in certain viruses aid in the replication of
necessary proteins for the survival and infectivity of the virus. Understanding these components
allows researchers to get one step closer to applying the knowledge we can learn in the lab to a
real-life medical application that has the potential to save lives.
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